Medical Device News Magazine

Smidt Heart Institute Proteins Expert Honored With Two Biomedicine Awards

Work of Jennifer Van Eyk, PhD, Centers on How Heart Disease Changes Proteins Found in the Body and How Proteins Differ in Men, Women

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Jennifer Van Eyk, PhD, director of the Advanced Clinical Biosystems Research Institute in the Smidt Heart Institute at Cedars-Sinai has been honored by two national organizations for her excellence and leadership in the field of biomedicine: the United States Human Proteome Organization (US HUPO) and Northeastern University’s Barnett Institute.

For more than 25 years, Van Eyk’s work has focused on clinical proteomics, the study of the structure and function of proteins within the body. Her research also is aimed at understanding how disease alters proteins differently in women with heart disease than men with heart disease.

“My team’s mission is to move our discoveries through the science pipeline and into the hands of clinicians to create better outcomes for patients,” said Van Eyk, the Erika J. Glazer Chair in Women’s Heart Health at Cedars-Sinai. “It’s an honor to have our work recognized by these prestigious organizations.”

The proteomics organization awarded Van Eyk the Catherine E. Costello Award for Exemplary Achievements in Proteomics, which recognizes a researcher who has made significant discoveries and accomplished scientific achievements. Van Eyk will be honored at the organization’s annual conference in Portland, Oregon, in March.

Van Eyk also has been awarded the biennial Karger Medal from the Barnett Institute at Northeastern University for her outstanding achievements in bioanalytical chemistry.

“Dr. Van Eyk is an international leader in this field,” said Eduardo Marbán, MD, PhD, executive director of the Smidt Heart Institute. “The discoveries coming out of her lab are changing the face of medicine. She richly deserves every recognition for her outstanding work.”

During 2023, Van Eyk’s work has received an abundance of honors. Earlier this year, Van Eyk also was recognized with the Distinguished Contribution Award from the Association for Mass Spectrometry and Advances in the Clinical Lab, the President’s Distinguished Lecture Award from the International Society for Heart Research, and a spot on the 2023 Ten Years of Impact Power List by The Analytical Scientist. Most recently, her research lab was included on first lady Jill Biden’s tour of Cedars-Sinai women’s health research.

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”